Schroeder, Brock
Zhang, Yi
Stål, Olle
Fornander, Tommy
Brufsky, Adam
Sgroi, Dennis C.
Schnabel, Catherine A.
Article History
Received: 10 March 2017
Revised: 5 July 2017
Accepted: 12 July 2017
First Online: 3 August 2017
Competing interests
: B.S., Y.Z., and C.A.S. disclose that they are employees and shareholders in Biotheranostics, Inc. A.B. discloses he is a consultant for Biotheranostics, Inc. Y.Z., C.A.S., and D.C.S. disclose they are named inventors on a patent to use the Breast Cancer Index, <i>HOXB13/IL17BR</i>, and Molecular Grade Index assays to predict breast cancer outcome. O.S. and T.F. have no relevant financial relationships with commercial interests to disclose.